Published in Infect Immun on November 01, 1983
V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J Virol (1993) 2.27
Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer. Pediatr Infect Dis J (2011) 1.10
Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol J (2009) 1.04
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
Disquisitions of Original Antigenic Sin. I. Evidence in man. J Exp Med (1966) 9.26
Interpandemic influenza in the Houston area, 1974-76. N Engl J Med (1978) 3.92
Evolution of human influenza A viruses in nature: recombination contributes to genetic variation of H1N1 strains. Proc Natl Acad Sci U S A (1979) 3.13
Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J Clin Microbiol (1979) 3.05
Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J Exp Med (1978) 2.99
Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations. Virology (1979) 2.45
Topological mapping antigenic sites on the influenza A/PR/8/34 virus hemagglutinin using monoclonal antibodies. Virology (1981) 1.87
Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol (1980) 1.74
The influenza herald wave. Am J Epidemiol (1982) 1.74
Maintenance of viability and comparison of identification methods for influenza and other respiratory viruses of humans. J Clin Microbiol (1977) 1.73
Evolution of human influenza A viruses in nature: sequential mutations in the genomes of new H1N1. Cell (1979) 1.68
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
Antigenic and genomic analyses of influenza A(H1N1) viruses from different regions of the world, February 1978 to March 1980. Infect Immun (1981) 1.55
Surveillance of influenza in Houston, Texas, USA: gradual transition from A/Victoria/75 (H3N2) to A/Texas/77 (H3N2) predominance and antigenic characterization of "intermediate" strains. Bull World Health Organ (1983) 0.83
Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol (2001) 21.17
Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature (2004) 16.76
Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet (1998) 16.30
To What Degree Are Mortality Statistics Dependable? Am J Public Health Nations Health (1940) 15.65
A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A (2000) 12.16
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol (1989) 10.63
Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature (2005) 10.04
Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A (2006) 9.26
Disquisitions of Original Antigenic Sin. I. Evidence in man. J Exp Med (1966) 9.26
A pandemic warning? Nature (1997) 8.70
Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci U S A (1999) 8.62
Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol (1998) 8.44
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (1994) 8.06
Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology (1998) 7.99
Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol (1999) 7.72
The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med (2001) 7.49
Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child (1986) 7.39
Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology (1978) 7.35
Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A (2005) 7.12
H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A (2004) 6.61
Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? J Virol (2001) 6.45
Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus. J Immunol (1967) 6.41
Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc Natl Acad Sci U S A (2002) 6.17
The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87
Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J Virol (2005) 5.78
Antiviral activity of antiserum specific for an influenza virus neuraminidase. J Virol (1968) 5.69
Molecular mechanisms of variation in influenza viruses. Nature (1982) 5.54
An outbreak of influenza aboard a commercial airliner. Am J Epidemiol (1979) 5.51
Evolution of swine H3N2 influenza viruses in the United States. J Virol (2000) 5.48
H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol (2000) 5.17
Replication of avian influenza viruses in humans. Arch Virol (1991) 5.10
Assembly of influenza hemagglutinin trimers and its role in intracellular transport. J Cell Biol (1986) 4.93
Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health (1987) 4.87
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology (1990) 4.71
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A (1993) 4.49
Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci U S A (2006) 4.49
H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology (2001) 4.46
The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine. Virology (1978) 4.43
Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci U S A (1988) 4.41
Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology (1993) 4.40
Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology (2000) 4.37
Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell (1987) 4.34
Potential for transmission of avian influenza viruses to pigs. J Gen Virol (1994) 4.24
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science (2013) 4.17
Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology (1984) 4.15
The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl. Can J Microbiol (1980) 4.14
A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol (1970) 4.12
Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes. Virology (1996) 4.04
Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis (1996) 4.04
Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev (1982) 4.03
Evolution of influenza A virus nucleoprotein genes: implications for the origins of H1N1 human and classical swine viruses. J Virol (1991) 4.01
Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr (1981) 4.00
Mortality and influenza. J Infect Dis (1982) 3.98
Interpandemic influenza in the Houston area, 1974-76. N Engl J Med (1978) 3.92
Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature (1979) 3.91
Is the gene pool of influenza viruses in shorebirds and gulls different from that in wild ducks? Virology (1988) 3.90
Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA (1985) 3.85
Characterization of an influenza A virus from seals. Virology (1981) 3.75
Studies on the origin of pandemic influenza. 3. Evidence implicating duck and equine influenza viruses as possible progenitors of the Hong Kong strain of human influenza. Virology (1973) 3.75
Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis (1971) 3.73
Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J Virol (1983) 3.70
Replication of avian influenza A viruses in mammals. Infect Immun (1981) 3.69
Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. Virology (2006) 3.59
Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet (2004) 3.54
Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology (1993) 3.54
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA (1999) 3.53
Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA (2000) 3.50
Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann Intern Med (1988) 3.49
Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis (1998) 3.47
Evolution of influenza A virus PB2 genes: implications for evolution of the ribonucleoprotein complex and origin of human influenza A virus. J Virol (1990) 3.40
Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. J Virol (1992) 3.37
Disquisitions on Original Antigenic Sin. II. Proof in lower creatures. J Exp Med (1966) 3.36
Characterization of the influenza A virus gene pool in avian species in southern China: was H6N1 a derivative or a precursor of H5N1? J Virol (2000) 3.35
The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology (1986) 3.34
Epitopes on protein antigens: misconceptions and realities. Cell (1990) 3.32
Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis (1981) 3.30
Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. J Virol (1991) 3.29
Conjunctivitis in human beings caused by influenza A virus of seals. N Engl J Med (1981) 3.27
Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature (1987) 3.26
Virulence of avian influenza A viruses for squirrel monkeys. Infect Immun (1982) 3.22
Immunity to influenza in man. Annu Rev Microbiol (1983) 3.22
A common surface antigen in influenza viruses from human and avian sources. J Gen Virol (1968) 3.20
Rapid evolution of H5N1 influenza viruses in chickens in Hong Kong. J Virol (1999) 3.20
Isolation and characterization of influenza A viruses from avian species in Hong Kong. Bull World Health Organ (1977) 3.17
Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol (2003) 3.15
The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005. J Virol (2007) 3.12
Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus. J Virol (1984) 3.11
Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J Clin Microbiol (1979) 3.05
Characterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses. J Clin Microbiol (1986) 3.04
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01
Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J Exp Med (1978) 2.99
Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. Virology (1995) 2.99
Ribavirin small-particle aerosol treatment of influenza. Lancet (1981) 2.91
Swine influenza viruses isolated in 1976 from man and pig contain two coexisting subpopulations with antigenically distinguishable hemagglutinins. Virology (1977) 2.90
Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Virology (1982) 2.78